Preclinical activity of MBM-5 in gastrointestinal cancer by inhibiting NEK2 kinase activity.
about
Preclinical activity of MBM-5 in gastrointestinal cancer by inhibiting NEK2 kinase activity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preclinical activity of MBM-5 ...... hibiting NEK2 kinase activity.
@en
Preclinical activity of MBM-5 ...... hibiting NEK2 kinase activity.
@nl
type
label
Preclinical activity of MBM-5 ...... hibiting NEK2 kinase activity.
@en
Preclinical activity of MBM-5 ...... hibiting NEK2 kinase activity.
@nl
prefLabel
Preclinical activity of MBM-5 ...... hibiting NEK2 kinase activity.
@en
Preclinical activity of MBM-5 ...... hibiting NEK2 kinase activity.
@nl
P2093
P2860
P356
P1433
P1476
Preclinical activity of MBM-5 ...... hibiting NEK2 kinase activity.
@en
P2093
Jianbei Xi
Mengli Zhu
Mingliang Ma
Tongtong Jiang
Xiongwen Zhang
Yanfen Fang
Yannan Kong
P2860
P304
79327-79341
P356
10.18632/ONCOTARGET.12687
P407
P50
P577
2016-10-15T00:00:00Z